Divestiture

Grupo Elektra resolves its decades-long tax dispute with Mexico, but a massive provision leads to a historic net loss, overshadowing solid operational growth.

The infrastructure giant posted a 12.2% EBITDA jump fueled by North American highways and a record construction backlog, solidifying its US-focused strategy.

The diagnostics firm topped revenue forecasts with explosive growth in core tests, navigating a net loss with a strategic pivot into new markets.

After a $544M annual loss from impairment charges, the performance parts maker is cutting costs and exploring the sale of its Marucci baseball brand.

After a strategic pivot to focus purely on cell and gene therapy, BioLife reports strong revenue growth and a profitable quarter, eyeing further gains in 2026.

FTAI Infrastructure's aggressive acquisitions drove an 82% jump in adjusted earnings, but hefty debt and transaction costs led to a significant net loss.

Clipper Realty's Q4 results show a stark divide in NYC real estate, as soaring apartment rents struggle to offset deep losses from its troubled office portfolio.

The City of Beaconsfield's lawsuit against Montréal over millions in alleged overcharges has a trial date, setting the stage for a landmark legal battle.

A century-old Chicago food dynasty, Pastorelli Food Products, sees its iconic recipes and brand name hit the auction block in a $2.8M foreclosure sale.

After a banner 2025, TriMas is selling its aerospace unit to double down on packaging, armed with a major cash infusion and a new efficiency plan.

Calyxo's CVAC System shows a dramatic reduction in repeat procedures and costs, but recent safety warnings add complexity to its widespread adoption.

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

Perrigo takes a massive $1.3B impairment charge and plans a 7% workforce reduction as it pivots to a 'CORE' business amid a challenging outlook.

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

Crescent's record production and strategic acquisitions paint a complex picture for investors amid a significant earnings beat but a notable revenue miss.

Despite lithium market weakness, AMG Critical Materials' adjusted EBITDA surged 40%, showcasing the power of its diversified portfolio and a strategic pivot.

As Nicholas Bell heads to the Royal Ontario Museum, Melanie Kjorlien will steer Glenbow's landmark reopening and its pioneering free admission model.

A new economic study finds West Virginia's greyhound racing industry doesn't pay for itself, surviving on millions in subsidies with no net benefit to the state.

An anonymous tipster's courage led to an $11 million recovery from a government contractor, highlighting the IRS program that rewards those who expose tax cheats.

The sale of the 344-unit Esperanza at Duarte Station highlights strong demand for transit-oriented luxury living, even as the broader LA market cools.